-The Hindu The terms of reference of the 15th Finance Commission raise questions about constitutional propriety It is not without reason that the presidential terms of reference (ToR) of the Fifteenth Finance Commission have raised questions, and the recent conclave of Finance Ministers of the southern States to discuss contentious issues in the ToR is only the beginning. In the months ahead more debate on this is likely. But the line by...

-The Indian Express To deal with corruption, it is not enough to just get fiscal policies right. It is in our collective long-term interest to nurture individual values. I went to an optometrist last week, who gave me one of those cards to read where the font starts out large and then gets progressively small, to test your reading capacity. In this case what was interesting was the content of the card....

-Hindustan Times The audit also recommended abolishing admission quotas, including those under the discretion of the vice-chancellor; no official reason was given for the audit. New Delhi: The Aligarh Muslim University must abolish separate colleges for male and female undergraduate students, do away with discretionary admission quotas and merge the departments for Sunni and Shia studies, a government-backed audit of the institution has suggested. These are among the top recommendations the audit made...

-TheWire.in The government should keep the secretary of the health department unchanged for three years for him/her to be able to show results. But that has not been happening. The NDA government had promised good governance and policy stability. Yet we have a fourth secretary in the health department in the last three years – the seventh in the last seven years. Since both the outgoing and the incoming officers have sterling...

-Down to Earth Why did we grant Pfizer's claim on a pneumonia vaccine which has been rejected elsewhere? In august, the medical and public health fraternity was stunned when India’s Patent Office granted US pharma giant Pfizer’s claim on its vaccine against pneumonia, the pneumococcal conjugate vaccine (PCV), marketed as Prevnar13. For a country that has stricter patentability criteria than most others, India’s decision was baffling because Pfizer’s patent has been rejected...